Screener
Ironwood Pharmaceuticals IRWD Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091987
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 199,201 | 274,178 |
| Property and equipment, net | 2,913 | 3,408 |
| Operating lease right-of-use assets | 8,443 | 9,340 |
| Intangible assets, net | 1,633 | 2,040 |
| Deferred tax assets | 69,064 | 103,433 |
| Other assets | 3,874 | 4,502 |
| Total assets | $285,128 | $396,901 |
| LIABILITIES AND STOCKHOLDERS' DEFICIT |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ironwood Pharmaceuticals's intangibles (net)?
- Ironwood Pharmaceuticals (IRWD) reported intangibles (net) of $1.63M in Q2 2026.
- How has Ironwood Pharmaceuticals's intangibles (net) changed year-over-year?
- Ironwood Pharmaceuticals's intangibles (net) decreased by 33.4% year-over-year, from $2.45M to $1.63M.
- What is the long-term trend for Ironwood Pharmaceuticals's intangibles (net)?
- Over 2 years (2023 to 2025), Ironwood Pharmaceuticals's intangibles (net) has grown at a -25.6% compound annual growth rate (CAGR), from $3.68M to $2.04M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Ironwood Pharmaceuticals's intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude